ALKS vs CAH · P/E 14, rev $1.56B vs P/E 35, rev $222.58B
Alkermes Plc (ALKS) versus Cardinal Health Inc (CAH) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported CAH revenue for 2025-06-30 was $222.58B. Net income was $1.57B. Revenue was down 1.9% from 2024-06-30 to 2025-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Not investment advice. Open the ALKS and CAH stock pages for the full models.
Not investment advice.